• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

849
71
51
50
32

COUNTRY

31
13
13
12
12

PRICE

681
866
973
1,574

PUBLISHED

26
68
328
1,574

PRODUCT TYPE

969
499
86
16
2
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic...

January 2014
FROM

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation...

January 2014
FROM

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation...

January 2014
FROM

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic...

January 2014
FROM

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current...

January 2014
FROM
Sexually-Transmitted Diseases in the UK 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in the UK 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in the UK 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,...

January 2014
FROM
Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities

This new 280-pages report presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in Germany 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Germany 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Germany 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,...

January 2014
FROM
World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers - Product Thumbnail Image

World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers

This new 389-page report from the author contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts...

January 2014
FROM
Consensus Outlook: Multiple Sclerosis Consensus Outlook: Multiple Sclerosis - Product Thumbnail Image

Consensus Outlook: Multiple Sclerosis

Over the next five years, the global multiple sclerosis (MS) market is set to grow from $14 3 billion in 2012 to $21 5 billion in 2017 Primary drivers of this growth will be the entry of new pipeline...

December 2013
FROM

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Shigella Infections (Shigellosis) - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Enterococcus Faecium Infections - Pipeline Review, H2 2013

Enterococcus Faecium Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Enterococcus Faecium Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Klebsiella Infections - Pipeline Review, H2 2013

Klebsiella Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Klebsiella Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Clostridium Difficile Infections (Clostridium Difficile Associated...

December 2013
FROM

Burkholderia Infections - Pipeline Review, H2 2013

Burkholderia Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Burkholderia Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Community-Acquired Infections - Pipeline Review, H2 2013

Community-Acquired Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Community-Acquired Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM
Loading Indicator

Our Clients

Our clients' logos